您的购物车当前为空
别名 LX6171
LX-6171是一种脯氨酸转运体(SLC6A7)抑制剂,可用于治疗精神分裂症和阿尔茨海默病。


为众多的药物研发团队赋能,
让新药发现更简单!
LX-6171是一种脯氨酸转运体(SLC6A7)抑制剂,可用于治疗精神分裂症和阿尔茨海默病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 606 | In Stock | |
| 5 mg | ¥ 1,490 | In Stock | |
| 10 mg | ¥ 2,230 | In Stock | |
| 25 mg | ¥ 3,590 | In Stock | |
| 50 mg | ¥ 5,180 | In Stock | |
| 100 mg | ¥ 7,330 | In Stock | |
| 200 mg | ¥ 9,880 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,530 | In Stock |
| 产品描述 | LX-6171, a proline transporter (SLC6A7) inhibitor, is used potentially for the treatment of schizophrenia and Alzheimer's disease. |
| 别名 | LX6171 |
| 分子量 | 377.87 |
| 分子式 | C22H20ClN3O |
| CAS No. | 914808-66-5 |
| Smiles | ClC=1C=C(C2=CC=C(C(=O)C3CCN(CC3)C=4N=CC=CN4)C=C2)C=CC1 |
| 密度 | 1.249 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 25 mg/mL (66.16 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容